Jonas Paludo, MD, Mayo Clinic, Rochester, MN, briefly explains the importance of studying RNA expression in rare diseases such as Waldenström’s macroglobulinemia (WM), and how this information may provide therapeutic options for patients beyond BTK inhibition. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Karyopharm and Biofourmis – both research funding to my institution